Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: ADSC secretome constrains NK cell activity by attenuating IL-2-mediated JAK-STAT and AKT signaling pathway via upregulation of CIS and DUSP4

Fig. 1

Intact viability and proliferation of NK-92 cells in the presence of the ADSC secretome. A Cell viability of IL-2-activated NK-92 cells incubated for 48 h with the ADSC secretome at various concentrations (horizontal axes) using CCK-8 assay. B Cell proliferation of IL-2-activated NK-92 cells treated as described in A for 96 h using CFSE staining assay. Error bars represent mean ± SEM of five independent experiments. Statistical significance was determined using one-way ANOVA with Dunnett’s multiple comparison test; not significant (ns)

Back to article page